The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J01 | Antibacterials for systemic use | |
| 3 | J01M | Quinolone antibacterials | |
| 4 | J01MB | Other quinolones |
| Code | Title | |
|---|---|---|
| J01MB01 | Rosoxacin | |
| J01MB02 | Nalidixic acid | |
| J01MB03 | Piromidic acid | |
| J01MB04 | Pipemidic acid | |
| J01MB05 | Oxolinic acid | |
| J01MB06 | Cinoxacin | |
| J01MB07 | Flumequine |
| Active Ingredient | Description | |
|---|---|---|
| Cinoxacin |
|
|
| Nalidixic acid |
Nalidixic acid is a quinolone antibacterial agent for oral administration. Nalidixic acid and related drugs have been shown to cause arthropathy in juvenile animals of most species tested. |
|
| Oxolinic acid |
|
|
| Pipemidic acid |
|